← Eichor
Condition: Hypertrophic Obstructive Cardiomyopathy Hocm Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hypertrophic Obstructive Cardiomyopathy Hocm

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of LX2006 Gene Therapy in Friedreich Ataxia Cardiomyopathy
Phase 2 · 1 location(s) · Lexeo Therapeutics · NCT07721025Treatment Effects of Bisoprolol and Verapamil in Symptomatic Patients With Non-obstructive Hypertrophic Cardiomyopathy
Phase 4 · 4 location(s) · Morten Steen Kvistholm Jensen · NCT05569382Positron Emission Tomography to Assess the Effect of Camzyos on Ischaemia in HOCM: PEACH Trial
NA · 1 location(s) · University of Manchester · NCT07120776A Study to Assess the Safety of Mavacamten in Korean Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Phase N/A · 2 location(s) · Bristol-Myers Squibb · NCT06146660Effect of Mavacamten Treatment on Coronary Flow Reserve in oHCM
Phase N/A · 1 location(s) · Michael Ayers · NCT06023186Mavacamten Enables Exercise in Hypertrophic Obstructive Cardiomyopathy
NA · 1 location(s) · Technical University of Munich · NCT07077005A Phase II Clinical Study of HRS-1893 in Non-obstructive Hypertrophic Cardiomyopathy
Phase 2 · 1 location(s) · Shandong Suncadia Medicine Co., Ltd. · NCT06816251Mavacamten Post-marketing Surveillance in Patients With Obstructive Hypertrophic Cardiomyopathy in Japan
Phase N/A · 1 location(s) · Bristol-Myers Squibb · NCT07383025Study of the Progression of Chronic Cardiovascular Conditions
Phase N/A · 1 location(s) · Prolaio · NCT07420907A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopa
Phase N/A · 15 location(s) · Bristol-Myers Squibb · NCT07361289Exercise Intolerance in Non-obstructive Hypertrophic Cardiomyopathy
NA · 1 location(s) · University of California, San Francisco · NCT05818605REFINE-HCM: Intramyocardial Septal Radiofrequency Ablation for Obstructive Hypertrophic Cardiomyopathy
NA · 2 location(s) · SuZhou Sinus Medical Technologies Co.,Ltd · NCT07006493A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes
Phase N/A · 99 location(s) · Bristol-Myers Squibb · NCT05489705Real-world Patient Reported Outcomes Among Patients Treated With Camzyos
Phase N/A · 1 location(s) · Bristol-Myers Squibb · NCT06551129Ademetionine in Obstructive Hypertrophic Cardiomyopathy
Phase 2 · 3 location(s) · China National Center for Cardiovascular Diseases · NCT07367724Effectiveness and Treatment Patterns of Mavacamten in Patients With Obstructive Hypertrophic Cardiomyopathy in Japan (MA
Phase N/A · 1 location(s) · Bristol-Myers Squibb · NCT07541833A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic
Phase 3 · 108 location(s) · Lexicon Pharmaceuticals · NCT06481891Mavacamten Outcomes in Hypertrophic Cardiomyopathy (HCM) and the Associated Patient and Physician Experiences in the US
Phase N/A · 1 location(s) · Bristol-Myers Squibb · NCT07557498Myocardial Perfusion Changes Following Optimal Medical Treatment in Symptomatic Hypertrophic Cardiomyopathy
Phase N/A · 1 location(s) · Medical University of Vienna · NCT07150299ENavogliflozin DElivering Alleviation of Ventricular Diastolic Dysfunction in nonObstRuctive Hypertrophic CardioMyopathy
Phase 4 · 1 location(s) · Yonsei University · NCT06580717A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopat
Phase 2/Phase 3 · 38 location(s) · Cytokinetics · NCT06412666Mavacamten to Aficamten Transition in Patients With Obstructive Hypertrophic Cardiomyopathy
Phase 4 · 2 location(s) · Oregon Health and Science University · NCT07600177DZHK TORCH-Plus is a Registry for Patients With Cardiomyopathies and Serves as Source for Cardiovascular Research Studie
Phase N/A · 1 location(s) · University Hospital Heidelberg · NCT04265040A Cardiac Disease Quality of Life Study
Phase N/A · 1 location(s) · The Cleveland Clinic · NCT04080492Egyptian Hypertrophic Cardiomyopathy Program
Phase N/A · 1 location(s) · Magdi Yacoub Heart Foundation · NCT05884892A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic C
Phase 2 · 67 location(s) · Imbria Pharmaceuticals, Inc. · NCT07023614Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MY
Phase 1/Phase 2 · 10 location(s) · Tenaya Therapeutics · NCT05836259A Phase III Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy
Phase 3 · 1 location(s) · Shandong Suncadia Medicine Co., Ltd. · NCT07021976
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.